Skip to main content

Biolog Wins $451,000 SBIR Grant for Antimicrobial Drug-Discovery Apps on Phenotype Microarray

NEW YORK, March 1 (GenomeWeb News) - Biolog has been awarded a phase I SBIR grant from the National Institute of Allergy and Infectious Disease to further develop its Phenotype Microarray technology for antimicrobial drug discovery.

 

The $451,000 award, provided from NIAID's biodefense program of the National Institutes of Health, will fund the application of the Phenotype Microarray technology as a tool to evaluate biologically active compounds using Staphylococcus aureus as the model organism, Biolog said.

 

Scientists at Biolog will screen 150 to 200 known chemicals against the S. aureus cellular array in order to develop a database that can be subsequently used for antimicrobial evaluation, Tim Mullane, Biolog's president and CEO, told GenomeWeb News today.

 

Pharmaceutical and biotech companies could then add profiles of chemicals from their libraries to the database, the company said.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.